Quick answer: To qualify a GHK-Cu supplier in China, do not compare catalogue “99% purity” figures first. Align the exact material identity, then review the current batch’s HPLC purity, mass-spectrometry identity support, copper-content method where relevant, COA-to-lot traceability, SDS and specification sheet, packaging, storage, MOQ, lead time, and quotation unit. A useful quote is one that lets procurement, quality, and formulation teams review the same defined material.
GHK-Cu sourcing becomes difficult when a buyer compares prices before confirming what each quote actually covers. One supplier may be quoting a cosmetic raw material, another a research-use vial, and a third a generic catalogue item with no batch-linked analytical package. They may all use the same shorthand name, yet they may not be comparable offers.
This guide is for B2B procurement, formulation, OEM/ODM, and distribution teams. It explains how to qualify a GHK-Cu / Copper Tripeptide-1 supplier without relying on marketing language, personal-use guidance, health claims, or unverified product promises.
Start by aligning the material identity
The first sourcing question is not price. It is: what exact material is being quoted?
| Term | What it means in a buyer review | RFQ action |
|---|---|---|
| Copper Tripeptide-1 | The INCI naming used for cosmetic ingredient and documentation review. | Use it in the specification sheet, COA, SDS, and quotation. |
| GHK-Cu | Common market shorthand for the copper complex of GHK. | Use it for search and discussion, then match it to formal documents. |
| GHK | The uncomplexed tripeptide, not the same material as the copper complex. | Do not treat it as interchangeable with GHK-Cu. |
| Copper peptide | Broad market language that may refer to more than one copper-containing peptide material. | Narrow the identity before comparing a supplier quote. |
For the copper complex, GHK-Cu is commonly referenced as CAS 89030-95-5. The uncomplexed GHK peptide is commonly referenced separately as CAS 49557-75-7. A buyer should confirm that the product name, CAS reference, specification sheet, COA, SDS, and quotation all describe the same material.
Identity alignment matters because a clean-looking COA cannot repair an incorrectly defined product. If the document names, CAS reference, or material form change from one file to another, pause the sourcing process and request clarification before comparing prices.
Treat HPLC purity, MS identity, copper content, and actual content as separate questions
The most common mistake in GHK-Cu sourcing is to read a single purity figure as if it proves everything. It does not.
| Check | What it can support | What it cannot establish by itself |
|---|---|---|
| HPLC purity | The chromatographic purity profile for a defined method and tested batch. | Molecular identity, copper content, or actual peptide content. |
| Mass spectrometry | Identity support through the expected molecular mass or mass pattern. | HPLC purity, elemental copper percentage, or fill amount. |
| Copper assay | The measured copper amount under the stated elemental method, such as ICP-OES, ICP-MS, or AAS. | Chromatographic purity, sequence identity, or actual peptide content. |
| Actual content assay | The amount of material present when a suitable method, standard, and calculation basis are defined. | It cannot be inferred from an HPLC area percentage alone. |
The theoretical copper content of the GHK-Cu complex is about 15.8% by weight, calculated from the molecular formula and copper atomic mass. That is a chemistry reference value, not a blanket release specification or a substitute for the current batch’s assay.
Free copper is a separate, project-specific question
Total copper content and free copper are not the same question. A stated elemental copper result describes the copper amount measured under its stated method; it does not by itself establish whether any copper is present in an uncomplexed form.
For a project that specifically requires this distinction, a free-copper assessment may be evaluated on a case-by-case basis. Qualitative differentiation between free and complexed copper can be explored by X-ray photoelectron spectroscopy (XPS), because their spectral positions differ. This is not a default batch-release claim, a universal "free-copper-free" statement, or a numeric free-copper result.
Any quantitative requirement should be defined separately with an appropriate validated method, including the applicable sample form, method scope, and reporting basis.
For the calculation and buyer-side interpretation, see GHK-Cu Copper Content: Why Purity Percentage Is Not Copper Content. This page stays focused on the broader supplier-qualification decision.
Read the current-batch COA before you compare a quotation
A product page or generic specification sheet tells a buyer what a supplier intends to offer. A current-batch COA tells the buyer what was reported for a particular lot. Both matter, but they do different jobs.
Before comparing GHK-Cu quotations, request a document package that lets the buyer connect the material definition to the actual lot:
| Document or field | What to check |
|---|---|
| Product identity | Copper Tripeptide-1 / GHK-Cu naming and CAS reference match the quotation. |
| Batch or lot number | The same identifier appears on the COA, HPLC report, identity record, and shipment or packaging record where applicable. |
| HPLC report | The report identifies the batch, includes the method context, and supports the reported purity result. |
| MS identity support | The record is relevant to the quoted material and its scope is clear: current batch or representative reference. |
| Copper-content support | If the downstream project needs it, request the result, method, and basis for the current batch. |
| Specification sheet | It states the material definition, relevant limits, storage, and handling conditions. |
| SDS / MSDS | It supports internal handling and shipment planning. |
| Dates and retest status | They are appropriate for the specific lot and planned use in the buyer’s project. |
A COA without a batch identifier is a product description, not a lot-release record. Likewise, a chromatogram without method context or clear lot linkage is not enough to make two suppliers comparable.
Separate cosmetic raw-material sourcing from research vial projects
The product form changes the buyer’s questions. A cosmetic raw-material review and a research-use lyophilized-vial project should not be treated as the same sourcing task.
| Project path | Buyer focus | Typical documentation and commercial questions |
|---|---|---|
| Cosmetic raw material | Ingredient identity, formulation fit, quality documents, packaging, and supply planning. | COA, HPLC, identity support, copper-content support where required, SDS, specification, MOQ, and storage. |
| Research-use vial | Defined vial-fill specification, batch documents, packaging, and project-level quotation. | Batch COA, HPLC, identity support, vial fill specification, packaging, document scope, and quote unit. |
| Private-label / OEM vial project | Material and fill configuration plus branding, packaging, and delivery coordination. | Vial count, fill specification, label/box scope, document requirements, project timing, and destination review. |
The cosmetic raw-material product path is available at Copper Tripeptide-1 (GHK-Cu). Teams evaluating a lyophilized-vial project can review GHK-Cu 50mg Vial. Neither page is intended to provide consumer, medical, or product-use guidance.
Ask whether the supplier can support a real technical review
For a serious B2B project, a supplier should be able to do more than send a price list. The supplier should be able to clarify the material definition, documentation scope, batch status, packaging path, and the limits of each analytical result.
The practical question is not whether a supplier reveals proprietary process parameters. It is whether the team can explain the quality and sourcing decisions that matter to the buyer:
- Can the team define the exact material and its relevant specification fields?
- Can it distinguish identity, purity, copper content, and actual content rather than treating them as the same claim?
- Can it identify which records are batch-specific and which are representative examples?
- Can it discuss manufacturing or sourcing path on a SKU-specific basis without making a blanket in-house claim?
- Can it clarify packaging, storage, MOQ, lead time, and quote unit before the buyer approves a project?
- Can it support project-specific formulation, documentation, or fill-format questions without drifting into unsupported end-use claims?
WUMO combines peptide process development, in-house production capability, batch-level testing, and project-specific support. Its peptide process-development work is led by Dr. Libo Du and a PhD-level technical team, which has led end-to-end GHK-Cu process development for manufacturing projects. Specific production or sourcing routes are confirmed by SKU and project; they should not be inferred from a generic product statement.
For broader company and document context, buyers can review Manufacturing & Quality, Quality & Compliance, and the document request center.
Normalize the quotation before deciding which offer is cheaper
Two GHK-Cu quotations can only be compared after they are normalized to the same scope.
| Quote field | Buyer question |
|---|---|
| Material identity | Is the quote for Copper Tripeptide-1 / GHK-Cu, with the expected CAS reference and material form? |
| Product format | Is it bulk cosmetic raw material, a lyophilized vial, or a private-label project? |
| Quality basis | What HPLC result, identity support, copper-content support, and actual-content basis are included? |
| Document scope | Are COA, HPLC, MS, SDS, and specification documents batch-specific, representative, or available only on request? |
| Packaging | What packaging unit, vial configuration, label, or outer-box scope is included? |
| MOQ | Is the MOQ based on grams, vials, boxes, available stock, or a production batch? |
| Lead time | Does it include material availability, quality review, fill and packaging, documentation, and dispatch? |
| Quote unit | Is the price stated per gram, per vial, per box, or per finished project? |
| Destination and project scope | Does the quotation reflect the buyer’s requested documents, destination, and intended B2B project type? |
A low number without this context may simply be a different offer. A specification-backed quote gives the buyer enough information to make an internal procurement, quality, and formulation decision without a second round of basic clarification.
Red flags that should pause the buying process
The following signals do not automatically disqualify a supplier. They do mean a buyer should pause and request clarification before placing a deposit, approving a sample, or comparing final prices.
- The product name, CAS reference, or material form changes across the quotation, COA, and specification sheet.
- A high purity claim is made without a batch-linked HPLC report or method context.
- HPLC purity is used to imply copper content, actual content, or complete identity verification.
- The supplier cannot explain whether MS or copper-content support is available for the quoted project.
- A COA has no identifiable batch or cannot be matched to the supporting analytical files.
- Salt form, packaging basis, or quote unit is not disclosed where it affects comparison.
- MOQ and lead time are given without clarifying stock, production, documentation, filling, or packaging scope.
- A supplier makes sterile, pharmaceutical-grade, all-in-house, or third-party-verified claims without product-specific evidence.
Prepare a specification-backed RFQ
A strong RFQ helps the supplier issue a useful answer and makes competing quotations easier to compare. Include the following fields:
| RFQ field | Why it matters |
|---|---|
| Product identity | Prevents GHK, GHK-Cu, and broad “copper peptide” terms from being mixed. |
| Required format | Sets the raw-material, vial, or private-label project path. |
| Documentation required | Defines COA, HPLC, MS, SDS, specification, or copper-content needs before the quote is prepared. |
| Quality requirements | Lets the supplier state what the applicable method and current batch can support. |
| Target quantity and quote unit | Prevents USD/g, USD/vial, and USD/box comparisons from being mixed. |
| Packaging requirements | Clarifies bulk packaging, vial configuration, label, or outer-box scope. |
| MOQ and timeline | Lets the supplier check stock, production, documentation, and packaging feasibility. |
| Destination and buyer type | Supports the right document, logistics, and project discussion without implying destination-market approval. |
If your team needs a formal GHK-Cu quotation, start with the specification and documents required for your project. Price can then be evaluated on a defined basis.
Frequently asked questions
Is GHK-Cu the same as Copper Tripeptide-1?
In cosmetic ingredient and sourcing discussions, GHK-Cu is commonly used as shorthand for Copper Tripeptide-1. Buyers should still confirm the exact product name, CAS reference, and material form in the current specification and batch documents.
What CAS number should buyers use for GHK-Cu?
GHK-Cu, the copper complex, is commonly referenced as CAS 89030-95-5. The uncomplexed GHK peptide is referenced separately as CAS 49557-75-7. They should not be treated as interchangeable materials in an RFQ or COA review.
Is HPLC purity the same as copper content?
No. HPLC purity describes a chromatographic purity result under a defined method. Copper content is a separate elemental measurement. A buyer who needs both should request both in the applicable batch documentation.
Can a supplier test for free copper in GHK-Cu?
Potentially, on a project-specific basis. Qualitative differentiation between free and complexed copper can be explored by XPS. This should not be read as a routine batch-release test, a guarantee that no free copper is present, or a quantitative result. If a project needs a numerical free-copper requirement, the method, sample form, and reporting basis should be agreed and validated separately.
Can HPLC prove the identity of the copper-peptide complex?
No. HPLC is useful for the chromatographic profile and purity. Molecular identity requires separate identity support, such as mass spectrometry, and copper content requires its own stated elemental method where relevant.
What should a buyer request before comparing GHK-Cu suppliers?
Request a specification sheet, current or representative COA, HPLC report, identity-support scope, SDS, packaging and storage information, plus the basis for copper-content support if it matters to the project. Then make sure the quote identifies the same material and format.
How can a buyer match an HPLC report to the quoted batch?
Check that the batch or lot identifier, product identity, document date, and method context can be matched to the COA and quotation. If the report is representative rather than batch-specific, ask the supplier to state that clearly.
What documents should accompany a B2B GHK-Cu quotation?
The appropriate package depends on the project, but commonly includes a specification sheet, COA, HPLC support, identity-support scope, SDS, and packaging or storage information. Research-use vial and private-label projects may need additional fill and packaging documentation.
Does a high purity figure prove actual peptide content?
No. A purity percentage is not an actual-content assay. Actual content requires an appropriate method, standard, and calculation basis; buyers should not assume it from an HPLC area percentage.
What should buyers clarify about MOQ, packaging, storage, and lead time?
Clarify whether MOQ is based on grams, vials, boxes, current stock, or a production batch; whether the lead time includes quality review and packaging; what storage and handling documents apply; and what packaging or label scope is included in the price.
How should cosmetic-grade GHK-Cu and research-use vial products be evaluated differently?
Cosmetic raw-material sourcing focuses on ingredient identity, formulation fit, documentation, packaging, and supply planning. Research-use vial projects add a defined vial-fill and packaging scope. Both require batch-document review, but neither should be presented as consumer or medical product guidance.
Request a specification-backed GHK-Cu quotation
If your team is evaluating GHK-Cu / Copper Tripeptide-1 for a qualified B2B project, share the required product format, target quantity, document package, packaging scope, quote unit, destination, and timeline. WUMO can review the specification and confirm the available documentation before issuing a formal quotation.
Request a Batch-Specific COA, HPLC/MS Documentation, and Specification Review